Related Experiment Video
Updated: Jun 16, 2026
06:55
Left Lung Orthotopic Transplantation in a Juvenile Porcine Model for ESLP
Published on: February 14, 2022
Inhaled epoprostenol during one-lung ventilation.
Karthik Raghunathan1, Neil Roy Connelly, Larry D Robbins
1Department of Anesthesiology, Baystate Medical Center, Tufts University School of Medicine, Springfield, Massachusetts 01199, USA. karthik.raghunathan@bhs.org
The Annals of Thoracic Surgery
|February 23, 2010
Summary
Inhaled epoprostenol improved oxygenation during one-lung ventilation in a severe interstitial lung disease patient. This highlights the underused potential of pharmacologic pulmonary blood flow manipulation for hypoxemia management.
Area of Science:
- Anesthesiology
- Pulmonology
- Cardiovascular Physiology
Background:
- Severe interstitial lung disease presents challenges during thoracic surgery.
- One-lung ventilation (OLV) can lead to hypoxemia.
- Managing hypoxemia during OLV is critical for patient outcomes.
Observation:
- A patient with severe ILD undergoing video-assisted thoracoscopic surgery (VATS) experienced hypoxemia during OLV.
- Inhaled epoprostenol was administered concurrently with intravenous phenylephrine to manage pulmonary blood flow.
- This intervention was specifically targeted to improve oxygenation during the OLV period.
Findings:
- The combined administration of inhaled epoprostenol and intravenous phenylephrine successfully improved oxygenation.
- This pharmacologic strategy effectively addressed the hypoxemia induced by OLV in this complex ILD patient.
- The study demonstrates a successful application of manipulating pulmonary vascular tone to enhance gas exchange.
Implications:
- Pharmacologic manipulation of pulmonary blood flow is a viable and potentially underused strategy for managing intraoperative hypoxemia.
- This approach may be particularly beneficial for patients with severe lung disease undergoing thoracic surgery.
- Further research into targeted pharmacologic interventions could optimize outcomes for patients requiring OLV.
Related Concept Videos
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:24Pulmonary Ventilation: Inhalation
Pulmonary ventilation is a vital process that ensures the exchange of oxygen and carbon dioxide in the lungs. It refers to the movement of air into and out of the lungs, enabling the body to obtain oxygen and remove waste carbon dioxide. In this article, we will explore the intricacies of pulmonary ventilation, including its underlying principles, mechanisms, and the interplay of pressures within the respiratory system.
Boyle's law becomes particularly pertinent when examining respiratory...
Boyle's law becomes particularly pertinent when examining respiratory...
01:14Ventilatory Modes
Mechanical ventilators are life-saving devices that support or replace spontaneous breathing. They deliver breaths to patients through varying methods known as ventilator modes. Understanding these modes is critical for healthcare providers managing patients with respiratory failure.
There are three ventilatory modes: full support, partial support, and spontaneous. These are described below.
Full Support Modes
Full support modes include controlled mechanical ventilation, continuous mandatory...
There are three ventilatory modes: full support, partial support, and spontaneous. These are described below.
Full Support Modes
Full support modes include controlled mechanical ventilation, continuous mandatory...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:27Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
01:23Inhaled Medications
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...